
Synlico develops CAR-T therapies and AI-driven drug discovery tools to advance cancer treatment. Its core technology combines systems biology, single-cell bioinformatics, and synthetic biology to design and optimize cell therapies. The platform uses a computation-centric iterative engineering process and AI-powered discovery to model T cell–tumor interactions across heterogeneous microenvironments. Target customers are biotech and pharmaceutical researchers seeking scalable, biology-driven solutions for oncology and related diseases.

Synlico develops CAR-T therapies and AI-driven drug discovery tools to advance cancer treatment. Its core technology combines systems biology, single-cell bioinformatics, and synthetic biology to design and optimize cell therapies. The platform uses a computation-centric iterative engineering process and AI-powered discovery to model T cell–tumor interactions across heterogeneous microenvironments. Target customers are biotech and pharmaceutical researchers seeking scalable, biology-driven solutions for oncology and related diseases.
Synlico Inc. is a resident company of Johnson & Johnson Innovation – JLABS, a premier life science incubator program. Synlico envisions rewriting medicine by bringing causality to cellular biology. We are an AI-powered Drug Discovery startup developing cutting-edge AI platform to combat diseases with the latest advancements in single-cell bioinformatics, machine learning, and causal discovery. We are a passionate team of young scientists and professionals who value innovation and teamwork. Our research is highly interdisciplinary and team oriented. We are seeking a talented and enthusiastic machine learning scientist who will lead/participate in several of our projects with our science team. Our HQ is at South San Francisco, CA, United States. For more information, please visit www.synlico.com.
Job Description:
This is a remote working position in Canada. What you will do
Job Requirement:
Interested candidates please submit your CV with a full list of your publications.